You are here

Study Evaluating Potential Pharmacokinetic (PK) Interaction Between Lecozotan and Digoxin

Last updated on February 23, 2019

FOR MORE INFORMATION
Study Location
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Alzheimer Disease
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-55 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Women of non childbearing potential and men aged 18 to 55 years at screening.

- Body mass index (BMI) in the range of 18 to 30 kg/m2 and body weight 50 kg (BMI =
weight (kg)/[height (m)]

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Presence or history of any disorder that may prevent the successful completion of the
study.

- Any clinically important deviation from normal limits in physical examination, vital
signs or clinical laboratory test results.

NCT00563732
Pfizer
Completed
Study Evaluating Potential Pharmacokinetic (PK) Interaction Between Lecozotan and Digoxin

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Alzheimer Disease, Healthy Subjects
NCT00795730
All Genders
18+
Years
Glendale, California
Alzheimer Disease, Healthy
NCT00719394
Males
20+
Years
Tokyo,

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now